All news

ResMed general counsel sells 400 shares at $255

Alpha Vantage · Kalkine · · AI-summarised by FinFlash

ResMed Inc.'s Global General Counsel and Secretary, Michael J. Rider, sold 400 shares of the company's common stock at $255 per share on October 23, 2026. This transaction was executed under a Rule 10b5-1 trading plan established on February 28, 2025. Following the sale, Rider's direct beneficial ownership in ResMed stands at 12,318 shares.

Read original source

RMD company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.